Biological determinants of difficult to treat patients with schizophrenia.
Sharma
T
T
Institute of Psychiatry, London.
Kerwin
R
R
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D001921:Brain / Q000473:pathology*; D003952:Diagnostic Imaging; D004351:Drug Resistance; D006801:Humans; D019965:Neurocognitive Disorders / Q000145:classification / Q000188:drug therapy / Q000503:physiopathology*; D012559:Schizophrenia / Q000145:classification / Q000188:drug therapy / Q000503:physiopathology*; D012565:Schizophrenic Psychology; D016896:Treatment Outcome
D014150:Antipsychotic Agents